Dr. Robert Greenblatt, M.D

NPI: 1861580433
Total Payments
$767.10
2024 Payments
$32.08
Companies
14
Transactions
52
Medicare Patients
2,496
Medicare Billing
$287,980

Payment Breakdown by Category

Food & Beverage$767.10 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $767.10 52 100.0%

Top Paying Companies

Company Total Records Latest Year
Salix Pharmaceuticals, a division of Bausch Health US, LLC $297.53 22 $0 (2024)
Valeant Pharmaceuticals North America LLC $88.56 5 $0 (2017)
Boston Scientific Corporation $66.01 4 $0 (2022)
Takeda Pharmaceuticals U.S.A., Inc. $53.58 4 $0 (2019)
PFIZER INC. $50.49 4 $0 (2021)
Becton, Dickinson and Company $44.76 1 $0 (2022)
GlaxoSmithKline, LLC. $39.89 3 $0 (2019)
Gilead Sciences, Inc. $29.50 2 $0 (2019)
Laborie Medical Technologies Corp. $24.39 2 $0 (2023)
Madrigal Pharmaceuticals $16.67 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $32.08 2 Madrigal Pharmaceuticals ($16.67)
2023 $24.39 2 Laborie Medical Technologies Corp. ($24.39)
2022 $93.07 4 Becton, Dickinson and Company ($44.76)
2021 $85.48 7 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($58.12)
2020 $55.30 4 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($55.30)
2019 $265.47 19 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($105.44)
2018 $76.39 6 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($63.26)
2017 $134.92 8 Valeant Pharmaceuticals North America LLC ($88.56)

All Payment Transactions

52 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/03/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $16.67 General
Category: LIVER DISEASE
01/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.41 General
Category: Gastroenterology
09/28/2023 Laborie Medical Technologies Corp. Food and Beverage Cash or cash equivalent $12.39 General
09/27/2023 Laborie Medical Technologies Corp. Food and Beverage Cash or cash equivalent $12.00 General
07/07/2022 INTERCEPT PHARMACEUTICALS, INC. OCALIVA (Drug) Food and Beverage In-kind items and services $14.72 General
Category: Hepatology / Gastroenterology
06/01/2022 Boston Scientific Corporation ORISE (Device) Food and Beverage In-kind items and services $18.93 General
Category: ORISE_ENDO
04/21/2022 Becton, Dickinson and Company Food and Beverage In-kind items and services $44.76 General
03/17/2022 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $14.66 General
Category: ENDOCRINOLOGY
10/13/2021 PFIZER INC. XELJANZ (Drug), INFLECTRA Food and Beverage In-kind items and services $13.54 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
09/15/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $11.92 General
Category: Gastroenterology
06/03/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $11.15 General
Category: Gastroenterology
05/25/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $11.86 General
Category: Gastroenterology
05/05/2021 Boston Scientific Corporation GENERAL HEMOSTASIS (Device) Food and Beverage In-kind items and services $13.82 General
Category: PAIN MANAGEMENT
03/15/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $12.10 General
Category: Gastroenterology
03/09/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $11.09 General
Category: Gastroenterology
12/09/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $12.61 General
Category: GASTROENTEROLOGY
11/25/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.41 General
Category: GASTROENTEROLOGY
10/01/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.25 General
Category: GASTROENTEROLOGY
03/31/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $13.03 General
Category: GASTROENTEROLOGY
12/05/2019 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.00 General
Category: GASTROENTEROLOGY
12/02/2019 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.29 General
Category: GASTROENTEROLOGY
09/19/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $17.20 General
08/29/2019 GlaxoSmithKline, LLC. ANORO (Drug) Food and Beverage In-kind items and services $14.28 General
Category: RESPIRATORY
08/21/2019 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.48 General
Category: GASTROENTEROLOGY
08/05/2019 Ferring Pharmaceuticals Inc. CLENPIQ (Drug) Food and Beverage In-kind items and services $13.24 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 474 656 $109,244 $65,561
2022 10 663 892 $193,797 $70,867
2021 10 839 1,129 $286,753 $100,034
2020 12 520 663 $143,805 $51,517
Total Patients
2,496
Total Services
3,340
Medicare Billing
$287,980
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 189 356 $53,803 $34,720 64.5%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 70 71 $16,403 $9,727 59.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 52 52 $10,407 $6,709 64.5%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 61 71 $12,102 $6,661 55.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 61 65 $6,794 $4,404 64.8%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 14 14 $3,852 $2,981 77.4%
45381 Injection beneath lining of large bowel using a flexible endoscope Facility 2023 27 27 $5,882 $358.64 6.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 217 404 $40,842 $27,717 67.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 88 113 $15,926 $10,873 68.3%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 84 87 $47,906 $9,797 20.5%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 78 90 $42,031 $8,362 19.9%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 26 26 $13,774 $5,475 39.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 36 36 $6,565 $4,684 71.3%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 14 15 $5,305 $1,374 25.9%
45381 Injection beneath lining of large bowel using a flexible endoscope Facility 2022 34 35 $18,389 $1,159 6.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 13 13 $1,600 $1,111 69.4%
82270 Stool analysis for blood to screen for colon tumors Office 2022 73 73 $1,460 $315.51 21.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 210 401 $41,984 $31,678 75.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 123 188 $27,672 $19,993 72.2%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 118 123 $73,043 $14,268 19.5%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 111 133 $68,785 $13,662 19.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 56 56 $11,301 $7,348 65.0%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 33 34 $21,394 $7,163 33.5%
45381 Injections beneath lining of large bowel, using a flexible endoscope Facility 2021 51 54 $32,512 $2,706 8.3%
43235 Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 13 16 $5,769 $1,475 25.6%

About Dr. Robert Greenblatt, M.D

Dr. Robert Greenblatt, M.D is a Gastroenterology healthcare provider based in Union, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861580433.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Greenblatt, M.D has received a total of $767.10 in payments from pharmaceutical and medical device companies, with $32.08 received in 2024. These payments were reported across 52 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($767.10).

As a Medicare-enrolled provider, Greenblatt has provided services to 2,496 Medicare beneficiaries, totaling 3,340 services with total Medicare billing of $287,980. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Union, NJ
  • Active Since 10/10/2006
  • Last Updated 12/13/2011
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1861580433

Products in Payments

  • XIFAXAN (Drug) $361.98
  • XELJANZ (Drug) $50.49
  • WATCHMAN (Device) $33.26
  • Entyvio (Biological) $32.19
  • ANORO (Drug) $26.75
  • RELISTOR (Drug) $24.11
  • ORISE (Device) $18.93
  • RESMETIROM (Drug) $16.67
  • OCALIVA (Drug) $14.72
  • CREON (Drug) $14.66
  • GENERAL HEMOSTASIS (Device) $13.82
  • CLENPIQ (Drug) $13.24
  • TRELEGY ELLIPTA (Drug) $13.14
  • LIALDA (Drug) $13.10
  • Motegrity (Drug) $12.84

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Union